1455 ADAMS DR MENLO PARK, CA 94025 Get Directions
1455 ADAMS DR MENLO PARK, CA 94025 Get Directions
Dr. Rampy joined CohBar as Chief Executive Officer in November 2011. Dr. Rampy is a Partner with Druid BioVentures (DBV), an emerging venture capital fund dedicated to creating and building virtual early stage life sciences companies. Previously he served as the Vice President, Business Development & Strategy, for Teva Pharmaceuticals North American Biologics and Specialty Pharmaceutical Group. Dr. Rampy has also served in an Advisory role to Red Abbey Venture Partners, a life sciences venture capital firm located in Baltimore, MD.
Prior to joining Teva, he was a Founder and Chief Business Officer of CoGenesys, Inc. a company spun out of Human Genome Sciences, Inc. (HGSI). Dr. Rampy played a key role in the initial start up, structure and execution of the CoGenesys spin-out including completion of a $55M Series A financing. During his tenure as CBO, Dr. Rampy was responsible for business development, licensing, intellectual property and commercial planning which lead to the acquisition of CoGenesys by Teva in 2008.
Before his tenure at CoGenesys, Dr. Rampy was with Human Genome Sciences, Inc. where he held positions of increasing responsibility concluding his eleven year tenure as Head of Business Development. While at HGS, Dr. Rampy was a driving force in forging multiple partnerships worth over $750M in direct funding, most notably of which were a $507MM partnership with Novartis and a $183M agreement with GlaxoSmithKline for the development of Syncria. While at HGSI, he positions of increasing responsibility in strategic marketing and business development. Dr Rampy began his career in
© Dun & Bradstreet, Inc. 2024. All rights reserved.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.